China Human Vaccine Industry Report, 2012-2015:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Design your online store. Shopify let's you create your online store easily. With total control over your website's design, state-of-the-art security & a fully hosted online shopping cart. From our sponsors

China Human Vaccine Industry Report, 2012-2015 Aug 17th 2013, 00:00, by rnrmahesh In the wake of China’s economic growth and enhanced disease prevention awareness, Chinese human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5 billion with the lot release quantity of roughly 773 million person-portions. Restricted by China’s national conditions and policies, EPI vaccines still prevail in China and Chinese EPI vaccine market is almost monopolized by state-run enterprises represented by CNBG Tiantan Biological, Biological Products Institutes in Changchun, Chengdu, Wuhan, Shanghai and Lanzhou, and Institute of Medical Biology of Chinese Academy of Medical Sciences in Kunming. In 2012, state-owned enterprises seized 81.5% of the vaccine lot … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=112049. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/china-human-vaccine-industry-report-2012-2015-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions